chevron_leftBack
As of 24 April 2025, Cochlear Ltd. has a market cap of $11.07B USD, ranking #1567 globally and #31 in Australia. It ranks #138 in the Healthcare sector, and #18 in the Medical Devices industry.
Key Stats
Market Cap
$11.07BUSD
17.34B AUD
Enterprise Value
$10.95BUSD
17.2B AUD
Revenue (TTM)
$1.47BUSD
2.31B AUD
EBITDA (TTM)
$361.51MUSD
568.0M AUD
Net Income (TTM)
$236.58MUSD
370.5M AUD
EBITDA Margin
25%
Profit Margin
16%
PE Ratio
47.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Diggory Howitt
open_in_new
Employees
5,097
Founded
1981
Website
cochlear.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.9% | 2.3% | -2.2% | -16% | -7.1% | -18% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
COH
Cochlear Ltd
ISIN: AU000000COH5
Shares Out.:
Shares Outstanding:
65.232M1
Shares Float:
61.694M2
|
265.13 AUD | |
|
CHEOF
Cochlear Ltd
ISIN: AU000000COH5
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
168.33 USD | |
|
CHEOY
Cochlear Ltd ADR
ISIN: US1914592050
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
83.67 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Cochlear Ltd.
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
